Back to Search
Start Over
Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.
- Source :
- Investigational New Drugs; Feb2012, Vol. 30 Issue 1, p316-326, 11p
- Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 01676997
- Volume :
- 30
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Investigational New Drugs
- Publication Type :
- Academic Journal
- Accession number :
- 104627943